Life is about so much more than Multiple Sclerosis

We invite those 18 to 55 years old who suffer from MS and have had at least 1 documented relapse in the last 24 months to see if they may be eligible to participate in the Radiance Study. The purpose of this clinical research study is to determine the safety and effectiveness of an investigational oral drug for relapsing multiple sclerosis.

Each individual will be evaluated to determine his or her eligibility. Those who participate will receive the study drug, study-related medical examinations, and laboratory tests at no charge. Compensation for time and travel may also be available.

RPC01-201_V1_Part B_Apr2013